Dominique Bouet DM '09

For my doctorate I examined the effects of Intellectual Property protection policies on innovation, and focused on the pharmaceutical industry in India. This enabled me to continue the international relationships in my current profession as a professor of management.

I am now at ESC-Pau business school in southern France. I work with the France-India MBA which gives me the opportunity to develop “business projects”. French and Indian students spend 4 months in India and work on cutting-edge missions for major companies like EY, Lafarge, Decathlon, Airbus, Schneider, Reliance, JSoft etc, some of them for many years now. The pedagogy is based on learning by doing, T-shaped competencies development, soft skills as well in depth academic competencies, methodologies and tools, etc. Missions include brand repositioning, cultural differences management, methodologies’ development, digital strategy, audit, etc. Executives from companies support each team, and provide constructive but uncompromising feedback.

I had moved to the USA from France for several years with my husband and our 3 children. Being part of the doctoral program was a great opportunity to increase my academic knowledge while staying strongly connected to business, and to share with my cohort members and my professors-- bringing in the French perspective. This was a very interesting learning experience that went far beyond the classroom.

My background is in Information System. I took a Master in Software computing (1986) and a MBA (1996). Before my doctoral degree at UMUC, I had a 17 years’ working experience with a number of global companies (Informix, Bull and Cap Gemini) on strategy and implementation of large-scale information systems including a position as a CIO of a major French agro-food company. I then joined a French business school as a professor of management. I am also pleased that my doctoral research has resulted in a recent article:

Bouet, D. (2015). A study of intellectual property protection policies and innovation in the Indian pharmaceutical industry and beyond. Technovation, 38, 31-41.